Bliss GVS Pharma Limited — Capital/Financing Update 2021

Apr 6, 2021

BLISS GVS ·PHARMA LTD.

April 06, 2021

T o	T o
T he M , L is ti D b t an ag er ng ep ar n en	he G al is ti T M L D tm t en er an ag er ng ep ar en ,
N io al S ck E h f In di L im it ed at to n xc an ge o a	B S E L im it ed
lo . C /1 G lo ck P B t no ,	P hi J je eb h T ro ze ee oy ow er s,
dr la pl dr B K C , B (E t) an a- ur om ex an a as ,	D al al S tr t, ee
M b ai 40 0 05 1 um -	b ai 40 0 00 1 M um -
b ol S : B L IS S G V S ym	S i C od 5 0 19 7 6 cr p e:

Subject: Grant of Options under Bliss GVS Pharma Limited- Employee Stock Options Plan 2019

Dear Sir/Madam,

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Para B of Part A of Schedule III of Listing Regulations and SEBI Circular No. CIR/ CFD / CMD / 4/ 2015 dated September 09, 2015, we would like to inform you that, the Members of Nomination and Remuneration Committee of the Board of Directors of the Company yesterday i.e. April 05, 2021 through circular resolution have approved grant of 7,30,000 Options out of balance 32,39,000 Options under Bliss GVS Pharma Limited- Employee Stock Options Plan 2019 ('ESOP-2019') to the eligible employees as per the details mentioned in 'Annexure -A'. Total number of shares covered by ESOP-2019 is 60,00,000 Equity Shares.

You are requested to take the aforementioned information on your records.

Thanking you.

Yours Faithfully, For Bliss GVS Pharma Limited

S. N. Karnath Managing Director DIN: 00140593

End: a/a

Factory: Regd. Office : 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL.: (+91) (22) 42160000/ 28505387 • FAX.: (+91) (22) 28563930, Email: info@blissgvs.com •Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. ·Email: factory@blissgvs.com

I ANNEXURE - A'

N o.	ic P la rt a rs u	D ai ls et
1	ri ef d ai ls f O io G d B et pt te o n s ra n	,3 0 ,0 00 (S ak h hi h d ) 7 L T T rt ev en s ou sa n y O io d of b al 32 ,3 9 ,0 00 pt te t n s gr an ou an ce O io d B li G V S P h L im it ed pt n s u n er ss ar m a pl ck io la b th E S O P 20 19 to pt m oy ee n s n y e in io d io N R at at om n an em n er n u it C te om m e.
2	W he th he ch is in of S E B I t t er s em e er m s 20 14 (S B E B ) R la ti (i f eg u on s, pl ic ab le ) ap	Y es
3	T al b of sh d b ot n u m er ar es co ve re y th ti es e op on s	N th 6 0 ,0 0 ,0 00 E it S h ot m or e an qu y ar es (E h k ti is ti bl in st to ac oc op on co nv er e iv al b f sh f fa al t eq u en n u m er o ar es o ce v u e of R 1/ ch ) e. ea -
4	P ri ci f ul ng or m a	E is P ri f R 4 3 / ti / xe rc e ce o s. p er o p on p er - sh b ed la lo si k B S E st et ar e as u p on c ng m ar ic d ed A il 1 20 2 1 af d ed in at te ct pr e pr r g u , di 57 % d in ed th b t et sc ou n as er m y e M b of N in io & R io at at em er s om n em un er n C it b ri if it in th te to om m e n g un or m y e ci ri f rl ie ti d te ex er se p ce o ea r op on s gr an on ch i. io M 7 , 2 02 0 2 7 ,6 1 ,0 00 O pt ar e. n s.
5	O io V d pt te n s es	0 ,2 50 O io 6 ,9 pt n s
6	T im it h in hi ch ti b e w w op on m ay e ci d ex er se	he ed ti sh al l b ci bl T st ve op on s e ex er sa e it h in io d of ( S ix ) m th fr he 6 t w a p er on s om da f in of h ti te st o ve g s uc op on s.
7	io ci d O pt n s ex er se	N il
8	M li d b ci f ti on ey r ea ze y ex er se o op on s	N il
9	he al b f sh ri si T t ot n u m er o ar es a ng a s a lt f ci f ti re su o ex er se o op on	il N
10	io la d O pt n s p se	il N
11	ia ti f of io V te pt ar on o rm s o n s	N A li bl ot pp ca e
12	ri ef d ai ls f si if ic B et t te o gn an rm s	i ) T he O io d ld V th t i pt te to n s gr an w ou es e n E li gi bl E pl 4 (f r) i al lm i st ts e m oy ee ou n en n in he f ol lo in t w g m an ne r: -

		f th l be of io (a ) 25 % O to ta pt o e nu m r ns
		d af 12 th fr th te te gr an r m on s, om e
		da f G of O io te nt pt o ra ns
		(b ) 25 % of he l be of O io t to ta pt nu m r ns
		d af 24 th fr th te te gr an r m on s, om e
		da f G of O io te nt pt o ra ns
		(c ) 25 % of he l be of O io t to ta pt nu m r ns
		d af 36 th fr th te te gr an r m on s, om e
		da f G of O io te nt pt o ra ns
		(d ) 25 of he l be of O io % t to ta pt nu m r ns
		d af 48 th fr th te te gr an r m on s, om e da f of io G O te nt
		pt o ra ns ii ) he ha ll be in im ri od of T re s a m um pe o ne
		be th of ti d tw t ye ar ee n e gr an op on s an
		in of io st pt ve g o ns
		iii ) he im ci ri od fo T m ax um ex er se pe r
		is of io ld be ix E O 6 (s ) pt xe rc e an n w ou
		th fr he d of it tin V t at m on s om e s es g.
		iv ) he it Sh is in of d T E V t te ar es ar ou es
		qu y g O io de th he sh al l be ub je pt ct ns un r e sc m e, s
		lo ck -i fo ri od of (s ix ) th 6 to n r a pe m on s
		fr he d of ll of E it Sh t at ot t om e a m en qu y ar es
13	Su bs ch ll io nt at eq ue an ge s or c an ce n or	N A li bl ot pp ca e
	ci f ch io pt ex er se o su o ns
14	ilu d in sh D te nt to ea rn gs pe r ar e pu rs ua is of it sh ci of	A li bl ti ha be N N ot pp ca e. o op on s ve en ci d
	su e e qu y ar es on ex er se ti on s	t. ex er se ye
	op